Clinical and gene therapy progress of acute spinal cord injury

Tengyue Fu,Fengjuan Wang,Shuaishuai Wu,Wenqiang Che,Xin Geng,Xiangyu Wang
DOI: https://doi.org/10.56293/ijasr.2023.5610
2023-01-01
Abstract:Acute spinal cord injury (ASCI) refers to the symptoms of sensory, motor dysfunction and defecation disorder in the parts below the level of spinal cord injury after the spinal cord is injured by various factors, which seriously affects the quality of life of the patient. ASCI is a common severe disabling disease in the field of neuroscience. Although the clinical treatment of spinal cord injury has made great progress, compared with the development of theoretical research, its clinical research progress is still insufficient. The most commonly used treatment methods at this stage are surgery and high-dose hormone pulse therapy. According to recent studies, the technology of in situ regeneration of neurons has received widespread attention and development due to its unique advantages of avoiding immune rejection of exogenous cell transplantation, risk of tumor formation, and in situ transformation of scar glial cells into neurons is expected to become a new therapeutic intervention for spinal cord injury.
What problem does this paper attempt to address?